MODERN ASPECTS OF KNEE JOINTS DEGENERATIVE-DYSTROPHIC LESIONS PATHOGENESIS AS A BASIS FOR CONSERVATIVE TREATMENT

Authors:

Abstract:

The purpose of the study was to provide a comprehensive overview of the pathophysiological mechanisms underlying degenerative-dystrophic joint damage and to identify therapeutic approaches to improve joint function and intra-articular cartilage nutrition. This review examines the current etiological factors and pathophysiological mechanisms of degenerative-dystrophic and inflammatory lesions of the large joints of the lower limbs, with a view to explaining the rationale for the use of prolotherapy with hypertonic glucose and/or dextrose solutions. A systematic analysis of studies from 2020 to 2025, drawn from the medical databases PubMed, Google Scholar, Web of Science, and SCOPUS, demonstrates the complexity and cascade of osteoarthrosis pathophysiological mechanisms, which significantly complicate the clinical manifestations of the disease and render drug therapy ineffective. The authors focus on prolotherapy, a regenerative medicine technique that uses hypertonic glucose and/or dextrose solutions, injected into damaged areas of the knee joint, to relieve chronic pain and stimulate the natural regeneration of intra-articular tissues. Clinical data confirms prolotherapy's efficacy in reducing pain and improving joint mobility, often achieving better results than traditional treatments. In their conclusion, the authors emphasize the alternative importance of prolotherapy for patients with gonarthrosis who are looking for non-invasive treatment options.

Keywords:

osteoarthrosis gonarthrosis pathophysiological mechanisms inflammation cytokines prolotherapy hypertonic glucose solution

References:

1. Lurin IA, Khomenko IP, Stepanov GF, Tertyshny SV, Vastyanov RS, Tiron OI. Zminy vmistu i aktyvnosti myazovykh bilkiv yak marker v razi vplyvu ionizuyuchoho oprominennya na tvaryn. Traumatology, orthopedics and prosthetics. 2024; 3: 49-56. doi: http://dx.doi.org/10.15674/0030-59872024349-56 [in Ukrainian].
2. Chernyavsky VV, Bailo AE, Onyshchuk LO, Tishchenko VV. Suchasni aspekty praktychnoho zastosuvannya symptomatychnykh preparativ spovilʹnenoyi diyi u likuvanni osteoartrytu (ohlyad literatury). Pain, joints, spine. 2024;14(2):96-105. doi: 10.22141/pjs.14.2.2024.423. [in Ukrainian].
3. Adam MS, Zhuang H, Ren X, Zhang Y, Zhou P. The metabolic characteristics and changes of chondrocytes in vivo and in vitro in osteoarthritis. Front Endocrinol (Lausanne). 2024; 15: 1393550. doi: 10.3389/fendo.2024.1393550.
4. Allen KD, Thoma LM, Golightly YM. Epidemiology of osteoarthritis. Osteoarthritis Cartilage. 2022; 30(2): 184-195. doi: 10.1016/j.joca.2021.04.020.
5. Andreyeva TO, Stoyanov OM, Chebotaryova GM, Kalashnikov VI, Vastyanov RS, Mashchenko SS. Densitometric correlates of degenerative-dystrophic processes in cervical vertebrae of humans and domestic animals. Regulatory Mechanisms in Biosystems. 2023; 14(3): 386-392. doi: 10.15421/022357.
6. Ansari MY, Ahmad N, Haqqi TM. Oxidative stress and inflammation in osteoarthritis pathogenesis: Role of polyphenols. Biomed Pharmacother. 2020; 129: 110452. doi: 10.1016/j.biopha.2020.110452.
7. Arias-Vázquez PI, Tovilla-Zárate CA, Castillo-Avila RG, Legorreta-Ramírez BG, López-Narváez ML, Arcila-Novelo R. et al. Hypertonic Dextrose Prolotherapy, an Alternative to Intra-Articular Injections With Hyaluronic Acid in the Treatment of Knee Osteoarthritis: Systematic Review and Meta-analysis. Am J Phys Med Rehabil. 2022; 101(9): 816-825. doi: 10.1097/PHM.0000000000001918.
8. Brophy RH, Fillingham YA. AAOS Clinical Practice Guideline Summary: Management of Osteoarthritis of the Knee (Nonarthroplasty), Third Edition. J Am Acad Orthop Surg. 2022; 30(9): 721-729. doi: 10.5435/JAAOS-D-21-01233.
9. Brylka LJ, Alimy AR, Tschaffon-Müller MEA, Jiang S, Ballhause TM, Baranowsky A. et al. Piezo1 expression in chondrocytes controls endochondral ossification and osteoarthritis development. Bone Res. 2024; 12(1): 12. doi: 10.1038/s41413-024-00315-x
10. Cherng JH, Chang SJ, Tsai HD, Chun CF, Fan GY, Reeves KD. et al. The Potential of Glucose Treatment to Reduce Reactive Oxygen Species Production and Apoptosis of Inflamed Neural Cells In Vitro. Biomedicines. 2023; 11(7): 1837. doi: 10.3390/biomedicines11071837.
11. Chlorogiannis DD, Taslakian B, Ahmed O, Mukundan A, Guermazi A, Ghodadra A. et al. Key Osteoarthritis Biomarkers: What Interventional Radiologists Performing Genicular Artery Embolization Need to Know. Cardiovasc Intervent Radiol. 2025; 48(6): 729-738. doi: 10.1007/s00270-025-04045-3.
12. D'Adamo S, Cetrullo S, Panichi V, Mariani E, Flamigni F, Borzм RM. Nutraceutical Activity in Osteoarthritis Biology: A Focus on the Nutrigenomic Role. Cells. 2020; 9(5): 1232. doi: 10.3390/cells9051232.
13. De Roover A, Escribano-Núñez A, Monteagudo S, Lories R. Fundamentals of osteoarthritis: Inflammatory mediators in osteoarthritis. Osteoarthritis Cartilage. 2023; 31(10): 1303-1311. doi: 10.1016/j.joca.2023.06.005.
14. Du X, Liu ZY, Tao XX, Mei YL, Zhou DQ, Cheng K. et al. Research Progress on the Pathogenesis of Knee Osteoarthritis. Orthop Surg. 2023; 15(9): 2213-2224. doi: 10.1111/os.13809.
15. Du G, Xiang C, Sang X, Wang X, Shi Y, Wang N. et al. Histone deacetylase 4 deletion results in abnormal chondrocyte hypertrophy and premature ossification from collagen type 2α1-expressing cells. Mol Med Rep. 2020; 22(5): 4031-4040. doi: 10.3892/mmr.2020.11465
16. Farpour H, Ashraf A, Hosseini SS. The efficacy of ozone prolotherapy compared to intra‐articular hypertonic saline injection in reducing pain and improving the function of patients with knee osteoarthritis: a randomized clinical trial. Evid Based Complement Alternat Med. 2021; 2021: 5579944. doi: 10.1155/2021/5579944.
17. Gelber AC. Knee Osteoarthritis. Ann Intern Med. 2024; 177(9): 129-144. doi: 10.7326/ANNALS-24-01249.
18. Hall M, van der Esch M, Hinman RS, Peat G, de Zwart A, Quicke JG. et al. How does hip osteoarthritis differ from knee osteoarthritis? Osteoarthritis Cartilage. 2022; 30(1): 32-41. doi: 10.1016/j.joca.2021.09.010.
19. Hsu C, Vu K, Borg-Stein J. Prolotherapy: A narrative review of mechanisms, techniques, and protocols, and evidence for common musculoskeletal conditions. Phys Med Rehabil Clin N Am. 2023; 34: 165–180. doi: 10.1016/j.pmr.2022.08.011
20. Hu W, Chen Y, Dou C, Dong S. Microenvironment in subchondral bone: predominant regulator for the treatment of osteoarthritis. Ann Rheum Dis. 2021; 80(4): 413-422. doi: 10.1136/annrheumdis-2020-218089.
21. Hunter DJ, Bowden JL, Hinman RS, Egerton T, Briggs AM, Bunker SJ. et al. Effectiveness of a New Service Delivery Model for Management of Knee Osteoarthritis in Primary Care: A Cluster Randomized Controlled Trial. Arthritis Care Res (Hoboken). 2023; 75(6): 1320-1332. doi: 10.1002/acr.25037.
22. Im YJ, Choi J, Choi SA, Kwon JY, Do JG. Feasibility and Preliminary Effectiveness of a Mobile App-Based Personalized Exercise Program in Older Patients With Chronic Knee Osteoarthritis: Pilot Randomized Controlled Trial. JMIR Mhealth Uhealth. 2025; 13: 71073. doi: 10.2196/71073.
23. Jiang Y. Osteoarthritis year in review 2021: biology. Osteoarthritis Cartilage. 2022; 30(2): 207-215. doi: 10.1016/j.joca.2021.11.009.
24. Khateri S, Nejad FB, Kazemi F, Alaei B, Azami M, Moradkhani A. et al. The effect of dextrose prolotherapy on patients diagnosed with knee osteoarthritis: A comprehensive systematic review and meta-analysis of interventional studies. Health Sci Rep. 2024; 7(6): 2145. doi: 10.1002/hsr2.2145.
25. Knights AJ, Redding SJ, Maerz T. Inflammation in osteoarthritis: the latest progress and ongoing challenges. Curr Opin Rheumatol. 2023; 35(2): 128-134. doi: 10.1097/BOR.0000000000000923.
26. Kolasinski SL, Neogi T, Hochberg MC, Oatis C, Guyatt G, Block J. et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Care Res (Hoboken). 2020; 72(2): 149-162. doi: 10.1002/acr.24131.
27. Kraus VB, Sun S, Reed A, Soderblom EJ, Moseley MA, Zhou K. et al. An osteoarthritis pathophysiological continuum revealed by molecular biomarkers. Sci Adv. 2024; 10(17): eadj6814. doi: 10.1126/sciadv.adj6814.
28. Larkina SA, Seletska OV, Makarenko OA, Vastyanov RS, Badiuk NS. Study of osteoplastic and anti-inflammatory efficiency of drugs containing calcium hydroxyapatite and hyaluronic acid. PharmacologyOnLine. 2021; 3: 958-967.
29. Lin J, Jia S, Zhang W, Nian M, Liu P, Yang L. et al. Recent Advances in Small Molecule Inhibitors for the Treatment of Osteoarthritis. J Clin Med. 2023; 12(5): 1986. doi: 10.3390/jcm12051986.
30. Liu K, Zhang B, Zhang X. Promoting Articular Cartilage Regeneration through Microenvironmental Regulation. J Immunol Res. 2024; 2024: 4751168. doi: 10.1155/2024/4751168.
31. Mahmoudian A, Lohmander LS, Mobasheri A, Englund M, Luyten FP. Early-stage symptomatic osteoarthritis of the knee - time for action. Nat Rev Rheumatol. 2021; 17(10): 621-632. doi: 10.1038/s41584-021-00673-4.
32. Maly K, Andres Sastre E, Farrell E, Meurer A, Zaucke F. COMP and TSP-4: Functional Roles in Articular Cartilage and Relevance in Osteoarthritis. Int J Mol Sci. 2021; 22(5): 2242. doi: 10.3390/ijms22052242.
33. Mao H, Han B, Li H, Tao Y, Wu W. FABP4 knockdown suppresses inflammation, apoptosis and extracellular matrix degradation in IL-1β-induced chondrocytes by activating PPARγ to regulate the NF-κB signaling pathway. Mol Med Rep. 2021; 24(6): 855. doi: 10.3892/mmr.2021.12495.
34. Mitsuzawa S, Yamashita S, Tsukamoto Y, Takeuchi H, Ota S, Onishi E. et al. What is the Optimal Treatment Protocol for Traumatic Popliteal Artery Injury? A Comparative Study between Two Institutions. J Emerg Trauma Shock. 2024; 17(3): 178-183. doi: 10.4103/jets.jets_164_23.
35. Molnar V, Matišić V, Kodvanj I, Bjelica R, Jeleč Ž, Hudetz D. et al. Cytokines and Chemokines Involved in Osteoarthritis Pathogenesis. Int J Mol Sci. 2021; 22(17): 9208. doi: 10.3390/ijms22179208.
36. Panichi V, Costantini S, Grasso M, Arciola CR, Dolzani P. Innate Immunity and Synovitis: Key Players in Osteoarthritis Progression. Int J Mol Sci. 2024; 25(22): 12082. doi: 10.3390/ijms252212082.
37. Peng X, Chen X, Zhang Y, Tian Z, Wang M, Chen Z. Advances in the pathology and treatment of osteoarthritis. JAdvRes. 2025; 30: 2090-1232(25). doi: 00072-4. doi: 10.1016/j.jare.2025.01.053
38. Pishgahi A, Abolhasan R, Shakouri SK, Soltani-Zangbar MS, Dareshiri S, Ranjbar Kiyakalayeh S. et al. Effect of Dextrose Prolotherapy, Platelet Rich Plasma and Autologous Conditioned Serum on Knee Osteoarthritis: A Randomized Clinical Trial. Iran J Allergy Asthma Immunol. 2020; 19(3): 243-252. doi: 10.18502/ijaai.v19i3.3452.
39. Primorac D, Molnar V, Rod E, Jeleč Ž, Čukelj F, Matišić V. et al. Knee Osteoarthritis: A Review of Pathogenesis and State-Of-The-Art Non-Operative Therapeutic Considerations. Genes (Basel). 2020; 11(8): 854. doi: 10.3390/genes11080854.
40. Raeissadat SA, Ghazi Hosseini P, Bahrami MH, Salman Roghani R, Fathi M, Gharooee Ahangar A. et al. The comparison effects of intra-articular injection of Platelet Rich Plasma (PRP), Plasma Rich in Growth Factor (PRGF), Hyaluronic Acid (HA), and ozone in knee osteoarthritis; a one year randomized clinical trial. BMC Musculoskelet Disord. 2021; 22(1): 134. doi: 10.1186/s12891-021-04017-x.
41. Reynard LN, Barter MJ. Osteoarthritis year in review 2019: Genetics, genomics and epigenetics. Osteoarthritis Cartilage. 2020; 28(3): 275-284. doi: 10.1016/j.joca.2019.11.010.
42. Rice SJ, Beier F, Young DA, Loughlin J. Interplay between genetics and epigenetics in osteoarthritis. Nat Rev Rheumatol. 2020; 16(5): 268-281. doi: 10.1038/s41584-020-0407-3.
43. Safiri S, Kolahi AA, Smith E, Hill C, Bettampadi D, Mansournia MA. et al. Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the Global Burden of Disease Study 2017. Ann Rheum Dis. 2020; 79(6): 819-828. doi: 10.1136/annrheumdis-2019-216515.
44. Sconza C, Leonardi G, Carfм C, Kon E, Respizzi S, Scaturro D. et al. Intra-articular injection of botulinum toxin for the treatment of knee osteoarthritis: a systematic review of randomized controlled trials. Int J Mol Sci. 2023; 24(2): 1486. doi: 10.3390/ijms24021486.
45. Tamteki N B, Gülsen Ersoy G. Our Surgical Results in Popliteal and Infrapopliteal Artery Injuries: 21 Cases without Amputation. Emerg Med Int. 2024; 2024: 1721047. doi: 10.1155/2024/1721047.
46. Tong L, Yu H, Huang X, Shen J, Xiao G, Chen L. et al. Current understanding of osteoarthritis pathogenesis and relevant new approaches. Bone Res. 2022; 10(1): 60. doi: 10.1038/s41413-022-00226-9.
47. Vo NX, Le NNH, Chu TDP, Pham HL, Dinh KXA, Che UTT. et al. Effectiveness and Safety of Glucosamine in Osteoarthritis: A Systematic Review. Pharmacy (Basel). 2023; 11(4):117. doi: 10.3390/pharmacy11040117.
48. Wee TC, Neo EJR, Tan YL. Dextrose prolotherapy in knee osteoarthritis: a systematic review and meta‐analysis. J Clin Orthop Trauma. 2021; 19: 108-117. doi: 10.1016/j.jcot.2021.05.015.
49. Żęgota Z, Goździk J, Głogowska-Szeląg J. Efficacy of herbal and naturally-derived dietary supplements for the management of knee osteoarthritis: a mini-review. Wiad Lek. 2021; 74(8): 1975-1983. doi: 10.36740/WLek202108134
50. Zhang M, Shan B, Lin S, Xu J, Zhang N. Editorial: Nutrition and metabolism in musculoskeletal disorders. Front Nutr. 2023; 10: 1269939. doi: 10.3389/fnut.2023.1269939.

Publication:

«World of Medicine and Biology» Vol. 21 No. 94 (2025) , с. 254-261
УДК 616.8-009.12-008.6-036.12-06 : 616.89-008.454]-092

DOI:

https://doi.org/10.26724/2079-8334-2025-4-94-254-261